Dogwood Therapeutics, Inc. Deferred Tax Assets, Gross
Dogwood Therapeutics, Inc. (DWTX) had Deferred Tax Assets, Gross of $37.44 million as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-03-18
- 2025-12-31: Deferred Tax Assets, Gross $37.44M.
- 2024-12-31: Deferred Tax Assets, Gross $38.27M.
- 2023-12-31: Deferred Tax Assets, Gross $10.14M.
- 2022-12-31: Deferred Tax Assets, Gross $9.02M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2025-12-31 | $37.44M 10-K · filed 2026-03-18 |
| 2024-12-31 | $38.27M 10-K · filed 2026-03-18 |
| 2023-12-31 | $10.14M 10-K · filed 2025-03-31 |
| 2022-12-31 | $9.02M 10-K/A · filed 2024-03-08 |
| 2021-12-31 | $5.97M 10-K · filed 2023-03-14 |
| 2020-12-31 | $2.26M 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |